South African Thoracic Society consensus statement on transbronchial lung cryobiopsy for interstitial lung disease
Article Sidebar
Main Article Content
Abstract
Background. Surgical lung biopsy (SLB), performed via open lung biopsy or video-assisted thoracoscopic surgery, has traditionally been the gold standard for diagnosing interstitial lung disease (ILD) when histological confirmation is necessary. Transbronchial forceps biopsy, while less invasive, often yields small, artifact-prone specimens that are insufficient for conclusive histopathological analysis. Transbronchial lung cryobiopsy (TBLC) has emerged as a minimally invasive alternative, offering a higher diagnostic yield and superior tissue integrity due to the retrieval of larger, en bloc samples. International societies currently conditionally recommended TBLC as a potential first-line diagnostic tool for ILD, citing its favourable safety profile and diagnostic performance.
Technique, procedural environment and complications. TBLC may be performed via flexible bronchoscopy with or without an artificial airway. When an artificial airway is used, general anaesthesia is administered, and a supraglottic device or endotracheal tube facilitates bronchoscope and blocker access. Without an artificial airway, the procedure is conducted under conscious sedation using an oral bite guard. A bronchial blocker is deployed to control bleeding, and biopsies are obtained under fluoroscopic guidance with freezing times of 6 - 10 seconds. At least four adequate samples (>5 mm) are collected. Post-procedure care includes positioning the patient with the biopsied lung in the dependent position and performing imaging to detect pneumothorax. While bleeding and pneumothorax are potential risks, they are generally manageable. Definitive exclusion criteria for TBLC have not yet been established, but characteristics such as severely impaired lung function, pulmonary hypertension and significant comorbidity are associated with adverse events.
Conclusion. Although TBLC yields marginally lower diagnostic rates compared with SLB, it remains a cost-effective and safer alternative, particularly in resource-limited settings. The South African Thoracic Society strongly advocates for TBLC as the first-line diagnostic modality in all cases of ILD, where histology is required, provided there are no contraindications. This recommendation is based on the lower cost and morbidity associated with TBLC compared with SLB. An exception is made for patients with non-diffuse or non-peribronchiolar disease who are suitable candidates for SLB and where the procedure is readily available. Strengthening local capacity and expertise in TBLC is crucial for improving ILD diagnostic accuracy in South Africa.
Downloads
Article Details
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
1. Rodrigues I, Gomes RE, Coutinho LM, et al. Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: A systematic review and meta-analysis. Eur Respir Rev 2022;31(166):210280. https:// doi.org/10.1183/16000617.0280-2021
2. Johannson KA, Marcoux VS, Ronksley PE, Ryerson CJ. Diagnostic yield and complications of transbronchial lung cryobiopsy for interstitial lung disease: A systematic review and metaanalysis. Ann Am Thorac Soc 2016;13(10):1828-1838. https://doi.org/10.1513/AnnalsATS.201606-461SR
3. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/ European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188(6):733-748. https://doi.org/10.1164/rccm.201308-1483ST
4. Troy LK, Grainge C, Corte T, et al. Cryobiopsy versus open lung biopsy in the diagnosis of interstitial lung disease (COLDICE): Protocol of a multicentre study. BMJ Open Respir Res 2019;6(1):e000443. https://doi.org/10.1136/bmjresp-2019-000443
5. Hetzel J, Maldonado F, Ravaglia C, et al. Transbronchial cryobiopsies for the diagnosis of diffuse parenchymal lung diseases: Expert statement from the Cryobiopsy Working Group on Safety and Utility and a call for standardisation of the procedure. Respiration 2018;95(3):188-200. https://doi.org/10.1159/000484055
6. Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis: An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018;198(5):e44-e68. https://doi.org/10.1164/rccm.201807-1255ST
7. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183(6):788-824. https://doi. org/10.1164/rccm.2009-040GL
8. Wells AU, Hirani N. Interstitial lung disease guideline: The British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008;63(Suppl 5). https://doi.org/10.1136/thx.2008.101691
9. Hutchinson JP, Fogarty AW, McKeever TM, Hubbard RB. In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States: 2000 to 2011. Am J Respir Crit Care Med 2016;193(10):1161-1167. https://doi.org/10.1164/ rccm.201508-1632OC
10. Freund O, Wand O, Schneer S, et al. Transbronchial cryobiopsy is superior to forceps biopsy for diagnosing both fibrotic and non-fibrotic interstitial lung diseases. Respiration 2023;102(9):852-860. https://doi.org/10.1159/000533197
11. Korevaar DA, Colella S, Fally M, et al. European Respiratory Society guidelines on transbronchial lung cryobiopsy in the diagnosis of interstitial lung diseases. Eur Respir J 2022;60(5):2200425. https://doi.org/10.1183/13993003.00425-2022
12. Lentz RJ, Argento AC, Colby TV, Rickman OB, Maldonado F. Transbronchial cryobiopsy for diffuse parenchymal lung disease: A state-of-the-art review of procedural techniques, current evidence, and future challenges. J Thorac Dis 2017;9(7):2186-2203. https://doi.org/10.21037/jtd.2017.06.96
13. Babiak A, Hetzel J, Krishna G, et al. Transbronchial cryobiopsy: A new tool for lung biopsies. Respiration 2009;78(2):203-208. https://doi.org/10.1159/000203987
14. Pajares V, Puzo C, Castillo D, et al. Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: A randomised trial. Respirology 2014;19(6):900-906. https:// doi.org/10.1111/resp.12322
15. Ravaglia C, Wells AU, Tomassetti S, et al. Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: A large cohort of 699 patients. BMC Pulm Med 2019;19(1):16. https://doi.org/10.1186/s12890-019- 0780-3
16. Ravaglia C, Bonifazi M, Wells AU, et al. Safety and diagnostic yield of transbronchial lung cryobiopsy in diffuse parenchymal lung diseases: A comparative study versus video-assisted thoracoscopic lung biopsy and a systematic review of the literature. Respiration 2016;91(3):215-227. https://doi.org/10.1159/000444089
17. Bondue B, Schlossmacher P, Allou N, et al. Trans-bronchial lung cryobiopsy in patients at high-risk of complications. BMC Pulm Med 2021;21:135. https://doi. org/10.1186/s12890-021-01503-9
18. Troy LK, Grainge C, Corte TJ, et al. Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): A prospective, comparative study. Lancet Respir Med 2020;8(2):171-181. https://doi.org/10.1016/ S2213-2600(19)30342-X
19. Maldonado F, Danoff SK, Wells AU, et al. Transbronchial cryobiopsy for the diagnosis of interstitial lung diseases: CHEST guideline and expert panel report. Chest 2020;157(4):1030-1042. https://doi.org/10.1016/j.chest.2019.10.048
20. Dhooria S, Mehta RM, Srinivasan A, et al. The safety and efficacy of different methods for obtaining transbronchial lung cryobiopsy in diffuse lung diseases. Clin Respir J 2018;12(4):1711-1720. https://doi.org/10.1111/crj.12734
21. Buckley AD, Singh N, Allwood BW, Lalla U, Koegelenberg CFN. The utility of transbronchial cryobiopsy performed under conscious sedation for interstitial lung diseases in a resource-constrained setting. Afr J Thorac Crit Care Med 2025;31(1):e2618. https://doi.org/10.7196/AJTCCM.2025.v31i1.2618
22. Esmail A, Tsoka K, Hofmeyr R, et al. Feasibility and safety of transbronchial lung cryobiopsy and mediastinal lymph node cryobiopsy: Experience from a resource- limited African setting. Afr J Thorac Crit Care Med 2025;31(1):e2448. https://doi. org/10.7196/AJTCCM.2025.v31i1.2448
23. Aliaga F, Vial MR. Cryobiopsies: Update on the tools, techniques, and evidence for malignancy, interstitial lung diseases, and lymph nodes. Curr Pulmonol Rep 2025;14(1):8. https://doi.org/10.1007/s13665-025-00372-5
24. Sharma D, Kumar Saini J, Sethi P, Kumar L, Kumar Dubey P. Assessing the effectiveness and safety of transbronchial lung cryobiopsy utilizing a flexible bronchoscope with an endobronchial blocker in diffuse parenchymal lung lesions. Monaldi Arch Chest Dis 2025;95(1). https://doi.org/10.4081/monaldi.2024.2887
25. Bian Y, Deng M, Gao Q, et al. The diagnostic efficiency and safety of transbronchial lung cryobiopsy using 1.1-mm cryoprobe in diagnosing interstitial lung disease. Lung 2024;202(5):615-623. https://doi.org/10.1007/s00408-024-00713-2
26. Park JH, Jang JH, Kim HK, et al. Transbronchial lung cryobiopsy for diagnosing interstitial lung disease: A retrospective single-center experience. Tuberc Respir Dis (Seoul) 2022;85(4):341-348. https://doi.org/10.4046/trd.2022.0031
27. Tomassetti S, Ravaglia C, Wells AU, et al. Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: A retrospective validation study. Lancet Respir Med 2020;8(8):786-794. https://doi. org/10.1016/S2213-2600(20)30122-3
28. Gershman E, Fruchter O, Benjamin F, et al. Safety of cryo-transbronchial biopsy in diffuse lung diseases: Analysis of three hundred cases. Respiration 2015;90(1):40-46. https://doi.org/10.1159/000381921
29. Kronborg-White S, Sritharan SS, Madsen LB, et al. Integration of cryobiopsies for interstitial lung disease diagnosis is a valid and safe diagnostic strategy – experiences based on 250 biopsy procedures. J Thorac Dis 2021;13(3):1455-1465. https://doi. org/10.21037/jtd-20-2431
30. Roberts ME, Rahman NM, Maskell NA, et al. British Thoracic Society Guideline for pleural disease. Thorax 2023;78(Suppl 3):s1-s42. https://doi.org/10.1136/ thorax-2023-220304
31. Iftikhar IH, Alghothani L, Sardi A, Berkowitz D, Musani AI. Transbronchial lung cryobiopsy and video-assisted thoracoscopic lung biopsy in the diagnosis of diffuse parenchymal lung disease: A meta-analysis of diagnostic test accuracy. Ann Am Thorac Soc 2017;14(7):1197-1211. https://doi.org/10.1513/AnnalsATS.201701-086SR
32. Aburto M, Pérez- Izquierdo J, Agirre U, et al. Complications and hospital admission in the following 90 days after lung cryobiopsy performed in interstitial lung disease. Respir Med 2020;165:105934. https://doi.org/10.1016/j.rmed.2020.105934
33. Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson Comorbidity Index: A critical review of clinimetric properties. Psychother Psychosom 2022;91(1):8-35. https://doi.org/10.1159/000521288
34. Casoni GL, Tomassetti S, Cavazza A, et al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS ONE 2014;9(2):e86716. https:// doi.org/10.1371/journal.pone.0086716
35. Katgi N, Çimen P, Çirak AK, et al. Complication and cost analysis of transbronchial lung cryobiopsy and awake video-assisted thoracic surgery in diagnosis of interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis 2022;39(1):e2022005. https://doi. org/10.36141/svdld.v39i1.12293